Publications
5891 Results
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 7028); American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
- Year
- 2013
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0919
SWOG S0919: A phase 2 study of idarubucin and cytarabine in combination with pravastatin for relapsed acute myeloid leukemia
- Journal / Conference
- Cancer Prevention Research 6(2):91-99;
- Year
- 2013
- Research Committee(s)
- Cancer Control
- PMID
- PMID23315596
- PMC
- PMC3565024
- Study Number(s)
- SWOG-9217
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Clinical Lung Cancer 14(6):627-635;
- Year
- 2013
- Research Committee(s)
- Lung
- PMID
- PMID23910067
- PMC
- PMC4122504
- Study Number(s)
- S0003, SWOG-9308, SWOG-9509, S9806
Chemotherapy outcomes by histological subtypes of non-small cell lung cancer: analysis of the SWOG database for antimicrotubule-platinum therapy
- Journal / Conference
- Medical Decision Making, 33(4):463-471;
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID2365833
- PMC
- PMC3933300
- Study Number(s)
- S1007
Value of information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics
- Journal / Conference
- Journal of Clinical Oncology 31(33):4179-4187;
- Year
- 2013
- Research Committee(s)
- Lung
- PMID
- PMID24002495
- PMC
- PMC3821010
- Study Number(s)
- E5597
A randomized, double blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in persons with resected stage I non-small cell lung cancer (ECOG 5597)
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 7511); ASCO Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
- Year
- 2013
- Research Committee(s)
- Lung
- Study Number(s)
- S0327, S0435, S0802
Relevance of platinum (plat) sensitivity status in previously treated extensive stage small cell lung cancer (ES-SCLC) in the modern era: a patient level analysis of SWOG trials
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr TPS657); 2013. American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), TIPS general poster session;
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- https://meetinglibrary.asco.org/record/86424/abstract
- Study Number(s)
- S1207
A phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor-(HR) positive and Her2-neu-negative breast cancer: SWOG-NSABP S1207
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 8562); ASCO Annual Meeting (May 31-June 4, 2013, Chicago, IL), general poster discussion;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0515
Markers of angiogenesis and hypoxia in germinal center B cell (GCB) and non-GCB subtypes of diffuse large B cell non-hodgkin lymphoma (DLBCL): correlative studies from S0515, a phase II trial of R-CHOP plus bevacizumab
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 9515); American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
- Year
- 2013
- Research Committee(s)
- Breast
The effect of renal function on outcomes in the adjuvant treatment of older women with breast cancer. An ancillary data study of CALGB/CTSU 49907 (for the Alliance for Clinical Trials in Oncology
- Journal / Conference
- Journal of Clinical Oncology 31(suppl; abstr 7527); American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
- Year
- 2013
- Research Committee(s)
- Lung
- Study Number(s)
- S0905